Inactive Instrument

Highlights Neothetics Inc Nasdaq

Equities

US64066G1013

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Evofem Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Evofem Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 27	CI
Evofem Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Evofem Biosciences, Inc. Provides Sales Guidance for the Third Quarter of 2023	23-10-24	CI
North American Morning Briefing : Treasury Yields Keep Pushing Higher	23-08-17	DJ
Evofem Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Evofem Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-06-16	CI
Evofem Biosciences, Inc. Receives Paragraph IV Certification Notice Letter from Padagis Israel Pharmaceuticals Ltd	23-05-05	CI
Evofem Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Evofem Biosciences, Inc.'s Phexxi Contraceptive Gel Added to SimpleHealth Product Offering	23-02-28	CI
Evofem Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	23-01-06	CI
Evofem Reports Top-Line Results from Phase 3 EVOGUARD Clinical Trial Evaluating EVO100 for Prevention of Chlamydia and Gonorrhea Infection in Women	22-10-11	CI
Evofem Biosciences Announces Approval of Phexxi in Nigeria	22-10-06	CI
Evofem Biosciences, Inc. Announces Issuance of U.S. Patent Covering Phexxi Composition of Matter	22-09-23	CI
Evofem Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
Evofem Biosciences, Inc. Affirms 2022 Guidance	22-08-04	CI
Evofem Biosciences, Inc. Announces Completion of Last Subject Last Visit in Registrational Phase 3 Evoguard Trial Evaluating Phexxi for the Prevention of Chlamydia and Gonorrhea in Women	22-08-01	CI
Evofem Biosciences Unveils New Educational Birth Control Chart to Assist Providers in Patient Contraceptive Counseling	22-07-25	CI
U.S. abortion ruling ignites retail interest in women contraceptive makers - Vanda	22-07-01	RE
Evofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent from United States Patent and Trademark Office	22-06-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Neothetics Inc Nasdaq

Equities

US64066G1013

Highlights

Filters